• Skip to primary navigation
  • Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Case reports
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • BC Issues until 2024
  • Submission
  • Istruction for authors
  • Search

CASI CLINICI – Case Reports

Volume:

Biochimica Clinica 2019; 43(4) e35-e36

Published on-line:

October 10, 2019

DOI:

10.19186/BC_2019.059

Download in PDF:
Authentication required

Una paziente con dolori ossei diffusi: il ruolo del laboratorio nel diagnosticarne la causa

AUTHORS

Daria Debbia1, Patrizia Natali1, Leonardo Ferrara2, Manuela Varani1, Giuseppe Longo2, Tommaso Trenti1
1Dipartimento di Medicina di Laboratorio e Anatomia Patologica, AOU-AUSL Modena
2Dipartimento integrato di Oncologia, Ematologia e Malattie dell’apparato respiratorio, AOU-Policlinico di Modena

ABSTRACT

A female patient with diffuse bone pain: the role of the clinical laboratory in the diagnostic process

Multiple myeloma (MM) represents 10% of all hematologic malignancies; in 15% of MM the monoclonal component consists of only free light chains. A 53 year-old patient performs at the Corelab laboratory (AOU-AUSL Modena) blood tests for bone pain. Serum electrophoresis shows hypogammaglobulinemia (5,5 g/L). The laboratory professional decides to carry on further studies: a serum immunofixation that highlighted the presence of kappa free light chains not traceable to any heavy chain and the measure of the serum free light chains (sFLC) with the following results: FLC-κ 26 777 mg/L (i.r. 3.3-19.4); FLC-λ 6.15 mg/L (i.r. 5.7-26.3); ratio FLC (rFLC), 435.31 (i.r. 0.26-1.65). The light chain MM is a type of MM difficult to recognize. The laboratory professional’s own initiative defines a procedure of “personalized medicine” oriented to to the patient’s needs. The expertise of the laboratory professional is crucial in assuring the patient the best outcome when carried out on the basis of the available guidelines.

REFERENCES